Pharmalot By Ed Silverman Pharmalot, Pharmalittle: The ‘Right to Try’ movement is spreading to Canada
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Drug makers warn German price controls will threaten access
Pharmalot By Ed Silverman Which drug makers do a good job getting poor patients access to their medicines?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Feds probe Express Scripts’s relationship with pharma
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: To avoid scandal, Novartis CEO advises companies not to hire rulebreakers
Pharmalot By Ed Silverman Novartis to pay $35 million to settle charges of illegally promoting a drug for infants
Pharmalot By Ed Silverman State Department accused of interfering with efforts for affordable medicines
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Novartis stops making TB drugs in Pakistan, prompting fear of a health crisis
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Novartis to spend $200 million to promote its flagging heart drug
Pharmalot By Ed Silverman Drug and device makers paid $6.5 billion to docs and teaching hospitals last year
Pharmalot By Ed Silverman Bernie Sanders accuses US Trade Rep of intimidating Colombia over Novartis patent